- Telehealth Visits
- Insurances Accepted
Yu-Ting (Tiffany) Meng, PharmD
She | Her | HersPharmacy- Telehealth Visits
- Insurances Accepted
Yu-Ting (Tiffany) Meng, PharmD
She | Her | HersPharmacy- Telehealth Visits
- Insurances Accepted
On this page
About me
Yu-Ting Meng, who goes by Tiffany, is a pharmacist who cares for patients with cancer, focusing particularly on breast cancer. She works with her patients to find the safest and most effective drug regimens for their conditions.
After earning her bachelor's degree in chemistry from the University of California, Irvine, Meng earned her doctor of pharmacy degree at UC San Diego. She completed a pharmacy residency at UCSF and an oncology pharmacy residency at Kaiser Permanente Diablo. She is certified in oncology pharmacy. She serves as a coordinator of UCSF's residency program in pharmacy and enjoys mentoring pharmacy residents as well as students at UCSF's pharmacy school.
In her free time, Meng enjoys exploring new restaurants, one bite at a time.
Education
Board Certification
- Oncology Pharmacist, Board of Pharmacy Specialties
Residency
- Oncology Pharmacy, Kaiser Permanente Medical Care Program,Diablo Area
- Pharmacy, UCSF School of Medicine -GME
School
- PHARMD, University of California San Diego School of Medicine
Care Keywords
Services
- Pharmacy
Clinical Trials query: q=health_gateway_id_ss%3A%28%223510%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=start_date_dt+asc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%223510%22%29&rows=4&sort=date_published+asc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.